Evidence map›Paper›PMID 39473651›Full record

ArticleCureus2024

Mobile Thrombus Observed Around an Impella Device.

Toru Miyoshi, Takashi Nishimura, Yu Hiasa, Hironori Izutani, Osamu Yamaguchi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Toru MiyoshiDepartment of Cardiology, Pulmonology, Hypertension, and Nephrology, Ehime University Graduate School of Medicine, Toon, JPN.
Takashi NishimuraDepartment of Cardiovascular Surgery, Ehime University Graduate School of Medicine, Toon, JPN.
Yu HiasaDepartment of Cardiology, Pulmonology, Hypertension, and Nephrology, Ehime University Graduate School of Medicine, Toon, JPN.
Hironori IzutaniDepartment of Cardiovascular Surgery, Ehime University Graduate School of Medicine, Toon, JPN.
Osamu YamaguchiDepartment of Cardiology, Pulmonology, Hypertension, and Nephrology, Ehime University Graduate School of Medicine, Toon, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An Impella device (Abiomed, Inc., Danvers, Massachusetts, United States) is a useful percutaneous left ventricular assist device for patients with cardiogenic shock. However, there are cases in which patients are unable to escape cardiogenic shock and become Impella-dependent. Long-term management can lead to thrombus. A man in his thirties experienced acute myocardial infarction necessitating Impella 5.5 support. Initially, a thrombus was not detected in the ascending aorta. Nonetheless, a mobile thrombus was observed post-Impella removal. His computed tomography revealed thrombosis in the iliac artery the following day. Diligent monitoring during Impella removal is imperative.

Indexed as

ascending aorta thrombosiscardiogenic shockimpellaleft ventricular assist device (lvad)transesophageal echocardiography

Identifiers

PMID39473651
PMCPMC11518699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.